E02.319.307.500

2 trials

Sponsors

Universidade Federal do Rio de Janeiro-UFRJ, Faculdade de Medicina de Ribeirão Preto- Universidade de São Paulo (FMRP-USP)

Conditions

Coronavirus infection, unspecified / COVID-19Vascular dementia

Phase 2

Effects of Nitazoxanide Administration to Patients in the Initial Phase of COVID-19

RecruitingRBR-4nr86m

Universidade Federal do Rio de Janeiro-UFRJCoronavirus infection, unspecified / COVID-19

Start: 2020-06-08Updated: 2025-10-27

Phase 3

Use of Cannabidiol in the treatment of psychiatric symptoms of Vascular Dementia

Active, not recruitingRBR-686kmpz

Faculdade de Medicina de Ribeirão Preto- Universidade de São Paulo (FMRP-USP)Vascular dementia

Start: 2021-08-06Updated: 2025-10-27

Related Papers

Effects of cannabidiol on behavioral and psychological symptoms of vascular dementia: A randomized, double-blind, placebo-controlled clinical trial.

2025-11-23